Image for post
Image for post

We Must Now Do Our Part to Ensure Companies Develop Scientific Breakthroughs Into Lifesaving Drugs

By Max Tokarsky

This week, 24 years ago, US President Ronald Reagan penned his now-famous letter to the American people announcing his diagnosis of Alzheimer’s. His letter marked the end of a larger-than-life public life and the beginning of a personal battle with a horrible disease, which robs us of our dignity and independence, steals our most precious memories, destroys lives and devastates millions of families.

By sharing their deepest fears and pain, Ronald and Nancy hoped to build awareness and lift the stigma of an Alzheimer’s diagnosis. …


Image for post
Image for post

Bill Gates’ venture philanthropy for Alzheimer’s is trailblazing — with Common Need Investment the rest of us can do our part to fix a broken system and power the search for a cure.

By Max Tokarsky

Bill Gates’ recent commitment to help establish the Alzheimer’s Diagnostic Accelerator at the Alzheimer’s Drug Discovery Foundation (ADDF), is trailblazing in many ways. Much has been written on the strategic choice to focus on diagnostics as a foundation for future breakthroughs. Not to be overlooked is the significance of structuring the $30 million partnership between Gates, Leonard Lauder, the Dolby family and the Charles and Helen Schwab Foundation as a form of venture philanthropy. A strategic charitable model which Dr. Howard Fillit, the Founding Executive Director and Chief Science Officer of ADDF, has fine-tuned to great effect.

What is venture philanthropy, you may ask?


Image for post
Image for post

Why Progress To Cure Cancer & Alzheimer’s Is Bottle-necked And A Simple Solution Within Our Reach

by Max Tokarsky

In the final episode of Mad Man, Henry, distraught by Betty’s resignation to late-stage lung cancer, pleads; “what do you think they would do if Roosevelt had this?” Betty’s stoic response is as profound as it is true .. “if Roosevelt had this, he would die.”

Fast forward 50 years, and while your iPhone has way more computing power than an office floor sized IBM of the Mad Man era, when it comes to diseases like late-stage lung Cancer or Alzheimer’s, “if Roosevelt had ‘this’, he would still die.” …


Image for post
Image for post

Wall Street Math Behind Pfizer’s Decision and A Bold Initiative To Ensure A Cure In Time

by Max Tokarsky

Today at the office, we were calculating the Alzheimer’s death toll worldwide and figured out that every 38 seconds another life is claimed. With Pfizer following other Big Pharma in downsizing or closing their Alzheimer’s research divisions, it is clear that due to the high cost and unpredictable nature of clinical stage research, the investment business model for Alzheimer’s drug discovery is simply broken.

Many drugs have shown potential in restoring brain connections and memory, and leading scientists believe that Alzheimer’s can be cured. …

About

Max Tokarsky

I’m a lifelong social entrepreneur, former non-profit executive, turned Impact Investment — Public Benefit Corporation model evangelist

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store